Chris Ogden

Chris Ogden

Senior Vice President, and Chief Financial OfficeratCytomX Therapeutics· In proxies 2024–2025

Pay in FY2025CytomX Therapeutics stock +313.6% the same year

Chris Ogden was paid $1.5M in FY2025 (Dec). CytomX Therapeutics stock rose 313.6% that year.

Pay$100 in the stock at the end of FY24 → $414
Pay is from the Summary Compensation Table of each CytomX Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytomX TherapeuticsPublic company · 2 yr
    • Senior Vice President, and Chief Financial Officer2024 – Present · 2 yrStock in role +59%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?